Related Experiment Video
Updated: Sep 7, 2025

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
Published on: January 29, 2016
Impact of supervised exercise training on systemic sclerosis with multiple organ involvement: A case report
Abdulrahman Mohammed Alhowikan1
1Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Abstract:
Supervised training exercises are the mainstay of pulmonary rehabilitation (PR) in patients with chronic lung diseases like interstitial lung disease (ILD). A 40 years old female patient with systemic sclerosis clinically presenting with usual interstitial pneumonia (UIP) and pulmonary hypertension underwent an eight-week supervised exercise training programme. Forced Vital Capacity (FVC) showed improvement from 48.7% to 54% of predicted baseline, while the initial six-minute walk test (MWT) distance also showed a considerable increase of 15.4% from the baseline after completion of the exercise training. A remarkable improvement was noticed in muscle strength for both the upper and the lower limbs. There was an increase of 79.4% right side handgrip, 25% left side handgrip, and 30.9% increase in lower limbs than baseline strength. The findings show that an exercise training programme under the supervision of trained and competent staff can benefit the improvement of lung function and muscle strength in a patient suffering from chronic lung diseases.
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Rheumatic Heart Disease I: Introduction

